• Issue

    American Journal of Hematology: Volume 97, Issue 4

    385-509, E129-E165
    April 2022
Previous Issue|Next Issue
Export Citation(s)Download PDF(s)

ISSUE INFORMATION

Free Access

Issue Information

  • Pages: 385-387
  • First Published: 10 March 2022

COMMENTARY

Free Access

Low-dose rituximab in immune thrombocytopenia: One and done

Marina Beltrami-Moreira,  James B. Bussel, 
  • Pages: 388-389
  • First Published: 07 February 2022

RESEARCH ARTICLES

Open Access

PD-L1 overexpression correlates with JAK2-V617F mutational burden and is associated with 9p uniparental disomy in myeloproliferative neoplasms

Jelena D. Milosevic Feenstra,  Roland Jäger,  Fiorella Schischlik,  Daniel Ivanov,  Gregor Eisenwort,  Elisa Rumi,  Michael Schuster,  Bettina Gisslinger,  Sigrid Machherndl-Spandl,  Peter Bettelheim,  Maria-Theresa Krauth,  Felix Keil,  Christoph Bock,  Mario Cazzola,  Heinz Gisslinger,  Robert Kralovics,  Peter Valent, 
  • Pages: 390-400
  • First Published: 11 January 2022
Free Access

Multicentric Castleman disease: A single center experience of treatment with a focus on autologous stem cell transplantation

Nadine H. Abdallah,  Thomas Habermann,  Francis K. Buadi,  Morie A. Gertz,  Martha Q. Lacy,  S. Vincent Rajkumar,  David Dingli,  Ronald S. Go,  Suzanne R. Hayman,  Shaji K. Kumar,  Taxiarchis Kourelis,  Rahma Warsame,  Prashant Kapoor,  Eli Muchtar,  Yi L. Hwa,  Amie L. Fonder,  Miriam A. Hobbs,  Yi Lin,  Nelson Leung,  Moritz Binder,  Mustaqeem A. Siddiqui,  Robert A. Kyle,  Thomas E. Witzig,  Angela Dispenzieri, 
  • Pages: 401-410
  • First Published: 11 January 2022
Open Access

Association of clonal hematopoiesis mutations with clinical outcomes: A systematic review and meta-analysis

Malgorzata K. Nowakowska,  Taebeom Kim,  Mikayla T. Thompson,  Kelly L. Bolton,  Anita Deswal,  Steven H. Lin,  Paul Scheet,  Mackenzie R. Wehner,  Kevin T. Nead, 
  • Pages: 411-420
  • First Published: 11 January 2022
Open Access

Adverse outcomes in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors: Follow-up of patients diagnosed 2002–2017 in a complete coverage and nationwide agnostic register study

Torsten Dahlén,  Gustaf Edgren,  Per Ljungman,  Hjalmar Flygt,  Johan Richter,  Ulla Olsson-Strömberg,  Hans Wadenvik,  Arta Dreimane,  Kristina Myhr-Eriksson,  Jingcheng Zhao,  Anders Själander,  Martin Höglund,  Leif Stenke, 
  • Pages: 421-430
  • First Published: 11 January 2022
Free Access

Paroxysmal nocturnal hemoglobinuria and vascular liver disease: Eculizumab therapy decreases mortality and thrombotic complications

Aurélie Plessier,  Marina Esposito-Farèse,  Anna Baiges,  Akash Shukla,  Juan Carlos Garcia Pagan,  Emmanuelle De Raucourt,  Isabelle Ollivier-Hourmand,  Jean-Paul Cervoni,  Victor De Ledinghen,  Zoubida Tazi,  Jean-Baptiste Nousbaum,  René Bun,  Christophe Bureau,  Christine Silvain,  Olivier Tournilhac,  Mathieu Gerfaud-Valentin,  François Durand,  Odile Goria,  Luis Tellez,  Agustin Albillos,  Stefania Gioia,  Oliviero Riggio,  Andrea De Gottardi,  Audrey Payance,  Pierre-Emmanuel Rautou,  Louis Terriou,  Aude Charbonnier,  Laure Elkrief,  Regis Peffault de la Tour,  Dominique-Charles Valla,  Nathalie Gault,  Flore Sicre de Fontbrune, 
  • Pages: 431-439
  • First Published: 20 January 2022
Free Access

Single-dose versus low-dose rituximab in corticosteroid-resistant or relapsed ITP: A multicenter, randomized, controlled study

Xiaofei Ni,  Daqi Li,  Chenglu Yuan,  Yafei Yu,  Haoyi Wang,  Lingjun Wang,  Tianshu Yu,  Ping Qin,  Jun Peng,  Ming Hou,  Yan Shi,  Yu Hou, 
  • Pages: 440-447
  • First Published: 20 January 2022
Open Access

A 29-gene signature associated with NOX2 discriminates acute myeloid leukemia prognosis and survival

Carla Ijurko,  Nerea González-García,  Purificación Galindo-Villardón,  Ángel Hernández-Hernández, 
  • Pages: 448-457
  • First Published: 24 January 2022
Free Access

Basiliximab for steroid-refractory acute graft-versus-host disease: A real-world analysis

Xiao-Dong Mo,  Shen-Da Hong,  Yan-Li Zhao,  Er-Lie Jiang,  Jing Chen,  Yang Xu,  Zi-Min Sun,  Wei-Jie Zhang,  Qi-Fa Liu,  Dai-Hong Liu,  Ding-Ming Wan,  Wen-Jian Mo,  Han-Yun Ren,  Ting Yang,  He Huang,  Xi Zhang,  Xiao-Ning Wang,  Xian-Min Song,  Su-Jun Gao,  Xin Wang,  Yi Chen,  Bing Xu,  Ming Jiang,  Xiao-Bing Huang,  Xin Li,  Hong-Yu Zhang,  Hong-Tao Wang,  Zhao Wang,  Ting Niu,  Ji-Shi Wang,  Ling-Hui Xia,  Xiao-Dan Liu,  Fei Li,  Fang Zhou,  Tao Lang,  Jiong Hu,  Sui-Jing Wu,  Xiao-Jun Huang, 
  • Pages: 458-469
  • First Published: 22 January 2022
Open Access

COVID-19 vaccines and risks of hematological abnormalities: Nested case–control and self-controlled case series study

Chor-Wing Sing,  Casey Tze Lam Tang,  Celine Sze Ling Chui,  Min Fan,  Francisco Tsz Tsun Lai,  Xue Li,  Eric Yuk Fai Wan,  Carlos King Ho Wong,  Esther Wai Yin Chan,  Ivan Fan Ngai Hung,  Anskar Yu-Hung Leung,  Ching-Lung Cheung,  Ian Chi Kei Wong, 
  • Pages: 470-480
  • First Published: 26 January 2022
Free Access

Health-related quality of life in patients with relapsed/refractory multiple myeloma treated with pomalidomide and dexamethasone ± subcutaneous daratumumab: Patient-reported outcomes from the APOLLO trial

Evangelos Terpos,  Meletios A. Dimopoulos,  Mario Boccadoro,  Sosana Delimpasi,  Meral Beksac,  Eirini Katodritou,  Philippe Moreau,  Alessandra Pompa,  Argiris Symeonidis,  Jelena Bila,  Albert Oriol,  Maria-Victoria Mateos,  Hermann Einsele,  Ioannis Orfanidis,  Katharine S. Gries,  John Fastenau,  Kevin Liu,  Jianming He,  Tobias Kampfenkel,  Yanping Qiu,  Himal Amin,  Robin Carson,  Pieter Sonneveld, 
  • Pages: 481-490
  • First Published: 28 January 2022

ANNUAL CLINICAL UPDATES IN HEMATOLOGICAL MALIGNANCIES

Free Access

Chronic neutrophilic leukemia: 2022 update on diagnosis, genomic landscape, prognosis, and management

Natasha Szuber,  Michelle Elliott,  Ayalew Tefferi, 
  • Pages: 491-505
  • First Published: 28 January 2022

CLINICAL PEARLS IN BLOOD DISEASES

MORPHOLOGY UPDATE

Free Access

Persistent neonatal jaundice resulting from hereditary pyropoikilocytosis

Gayathriy Sivaguru,  Giulia Simini,  Barbara J. Bain, 
  • Pages: 506-507
  • First Published: 22 September 2021

IMAGES IN HEMATOLOGY

Free Access

Hemophagocytic lymphohistiocytosis, what about hair?

Baptiste Le Calvez,  Caroline Thomas,  Alice Huault,  Elisabeth Cassagnau,  Marie C. Béné,  Marion Eveillard, 
  • Pages: 508-509
  • First Published: 30 September 2021

CORRESPONDENCES

Free Access

Hemolytic anemia following alectinib reported to the U.S. Food and Drug Administration Adverse Event Reporting System

Graça M. Dores,  Afrouz Nayernama,  Connie Cheng,  Charlotte Moureaud,  S. Christopher Jones, 
  • Pages: E129-E132
  • First Published: 05 January 2022
Free Access

COVID-19 vaccine response in patients with hematologic malignancy: A systematic review and meta-analysis

Inna Y. Gong,  Abi Vijenthira,  Stephen D. Betschel,  Lisa K. Hicks,  Matthew C. Cheung, 
  • Pages: E132-E135
  • First Published: 10 January 2022
Free Access

Sequential next generation sequencing analysis in homogeneously treated low risk NPM1-mutated acute myeloid leukemia with an adverse clinical outcome

Marianna Rossi,  Maria Elena Nizzoli,  Anna Gallì,  Elisa Roncoroni,  Silvia Zibellini,  Gabriele Merati,  Ettore Rizzo,  Barbara Rocca,  Daniela Pietra,  Cristina Picone,  Marco Brociner,  Claudia Patricia Tobar Cabrera,  Eleonora Gelli,  Eugenio Santacroce,  Luca Arcaini,  Patrizia Zappasodi, 
  • Pages: E135-E138
  • First Published: 18 January 2022
Free Access

Midostaurin therapy for indolent and smoldering systemic mastocytosis: Retrospective review of Mayo Clinic experience

Faiqa Farrukh,  Naseema Gangat,  Mithun V. Shah,  Mark R. Litzow,  Michelle A. Elliott,  Kebede Begna,  Christopher C. Hook,  Ayalew Tefferi,  Animesh Pardanani, 
  • Pages: E138-E140
  • First Published: 11 January 2022
Free Access

BNT162b2 mRNA SARS-CoV-2 vaccination does not cause upregulation of endothelial activation markers or hypercoagulability: A prospective, single-arm, longitudinal study

Xin Rong Lim,  Bernard PuiLam Leung,  Christina Lai Lin Sum,  Gek Hsiang Lim,  Choon Guan Chua,  Tian Ming Tu,  Kollengode Ramanathan,  Mei Yan Huang,  Hwee Siew Howe,  Bingwen Eugene Fan, 
  • Pages: E141-E144
  • First Published: 11 January 2022
Free Access

A population-based study of acute panmyelosis with myelofibrosis in the United States: 2004–2015

Nicole McLaughlin,  Gordon Ruan,  Courtney N. Day,  William S. Harmsen,  Caleb J. Smith,  Moritz Binder,  Naseema Gangat,  Ronald S. Go,  Ayalew Tefferi,  Mithun Vinod Shah, 
  • Pages: E144-E147
  • First Published: 13 January 2022
Free Access

Third dose of the BNT162b2 vaccine results in very high levels of neutralizing antibodies against SARS-CoV-2: Results of a prospective study in 150 health professionals in Greece

Evangelos Terpos,  Vangelis Karalis,  Aimilia D. Sklirou,  Filia Apostolakou,  Ioannis Ntanasis-Stathopoulos,  Tina Bagratuni,  Vassiliki A. Iconomidou,  Panagiotis Malandrakis,  Eleni Korompoki,  Ioannis Papassotiriou,  Ioannis P. Trougakos,  Meletios A. Dimopoulos, 
  • Pages: E147-E150
  • First Published: 13 January 2022
Free Access

Serum erythropoietin levels in 696 patients investigated for erythrocytosis with JAK2 mutation analysis

Benjamin Chin-Yee,  Ian Cheong,  Maxim Matyashin,  Alejandro Lazo-Langner,  Ian Chin-Yee,  Vipin Bhayana,  Pratibha Bhai,  Hanxin Lin,  Bekim Sadikovic,  Cyrus C. Hsia, 
  • Pages: E150-E153
  • First Published: 19 January 2022
Free Access

Real-world applicability of commercial chimeric antigen receptor T-cell therapy among older adults with relapsed and/or refractory multiple myeloma

Smith Giri,  Susan Bal,  Kelly N. Godby,  Gayathri Ravi,  Deanna Clark,  Clare Ubersax,  Abigail Cooley,  Priscila White,  Sunil Rangarajan,  Grant R. Williams,  Luciano J. Costa, 
  • Pages: E153-E155
  • First Published: 19 January 2022
Free Access

Clinical phenotypes of three children with sickle cell disease caused by HbS/Sicilian (δβ)0-thalassemia deletion

Banu Aygun,  Adriana Bello,  Alexis A. Thompson,  Lance Davis,  Yanan Sun,  Hong-yuan Luo,  Shuaiying Cui,  David H. K. Chui, 
  • Pages: E156-E158
  • First Published: 19 January 2022
Free Access

TP53 mutations at codon 234 are associated with chlorambucil treatment in chronic lymphocytic leukemia

Grégory Lazarian,  Floriane Theves,  Myriam Hormi,  Rémi Letestu,  Virginie Eclache,  Audrey Bidet,  Pascale Cornillet-Lefebvre,  Frédéric Davi,  Eric Delabesse,  Marie-Hélène Estienne,  Pascaline Etancelin,  Olivier Kosmider,  Sophy Laibe,  Laurence Lode,  Marc Muller,  Nathalie Nadal,  Dina Naguib,  Cédric Pastoret,  Stéphanie Poulain,  Pierre Sujobert,  Lauren Veronese,  Samia Imache,  Valérie Lefebvre,  Florence Cymbalista,  Fanny Baran-Marszak,  Thierry Soussi,  French Innovative Leukemia Organisation (FILO) , 
  • Pages: E159-E162
  • First Published: 26 January 2022
Free Access

Drug (vaccine)-induced thrombocytopenia 2021: Diversity of pathogenesis and clinical features

Sanober Nusrat,  Azra Borogovac,  James N. George,  Brian R. Curtis,  Jessica A. Reese, 
  • Pages: E162-E165
  • First Published: 29 January 2022